NCT07011862进行中（未招募）不适用
COBRA: Cancer, Older Adults, Balance and Resistance Activities
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 38
- 试验地点
- 12
- 主要终点
- Rate of retention and adherence to the COBRA/Cancer, Older Adults, Balance and Resistance Activities intervention
研究概览
简要总结
The purpose of this study is to find out whether an 8-week digital health promotion program called COBRA is a safe and practical (feasible) option for older adults with cancer/OAC.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Older Adult Patients with Cancer
- •- Are within 1 year of completion of primary therapy for cancer OR have a diagnosis of metastatic cancer;
- •For the purpose of this study, primary therapy is defined as treatment of curative intent, first-line or later, from which the individual is advancing to active surveillance or follow-up with or without maintenance therapy.
- •Individuals with metastatic cancer may be included provided they have stable disease or better per most recent restaging exam at time of enrollment.
- •i. Patients with stable metastatic bony disease at most recent restaging exam and a score of 0-2 on the Functional Pain Scale (FPS69; Appendix 18) are eligible. The PI will consult with the Rehab Med co-PI for FPS scores of 3 or greater, by patient request or PI discretion.
- •ii. Patients with symptomatic visceral metastases will be evaluated on a case-by-case basis at time of enrollment.
- •Are aged 65 years and older, with no upper age limit;
- •ECOG PS 0-3 or Karnofsky PS greater than or equal to 40;
- •Can read and speak English;
- •Self-report access to internet connection sufficient to support videoconferencing.
- •Licensed clinician (MD, RN, APP) with an interest in the care of older adults with cancer.
排除标准
- •Older Adult Patients with Cancer
- •Have any cognitive impairment, neurologic, musculoskeletal, or other comorbid condition (as assessed by their provider) that would prevent the individual from engaging with the digital health coaching program or complete study assessments or engage in progressive intensity levels of physical activity
- •Have a neurologic, musculoskeletal, or other comorbid condition that would impede their ability to safely engage in progressive intensity levels of physical activity (as assessed by their provider). Patients with metastatic disease and suspected interim progression since last restaging exam will be referred back to their primary oncology care team for evaluation prior to enrollment.
- •Have activity restrictions post-surgery at the time of enrollment
- •Clinicians No expected exclusions
研究组 & 干预措施
Older Adult Patients/OAP
Experimental
Older Adult Patients with Cancer are within 1 year of completion of primary therapy for cancer OR have a diagnosis of metastatic cancer;
干预措施: Cancer, Older adults, Balance and Resistance Activities (Behavioral)
结局指标
主要结局
Rate of retention and adherence to the COBRA/Cancer, Older Adults, Balance and Resistance Activities intervention
时间窗: 8 weeks
Rate of retention and adherence to the 8-week intervention to define intervention feasibility
次要结局
未报告次要终点
研究者
研究点 (12)
Loading locations...
相似试验
尚未招募
不适用
The Effectiveness of a Health Promotion Program for Older People With Post-Covid-19 SarcopeniaPost COVID-19 ConditionNCT06211686Mahidol University50
已完成
不适用
Diet and Activity Promotion Among Older Working AdultsAgingDiabetesCardiovascular DiseaseObesityNCT01233063Berkeley Analytics, Inc.610
已完成
不适用
Enhancing Quality of Life for Older Adults With and Without Mild Cognitive Impairment (MCI) Through Social Engagement Over Video TechnologyAgingMild Cognitive ImpairmentAging WellNCT05380180University of Illinois at Urbana-Champaign99
尚未招募
不适用
A Digital Health Program for Non-Communicable Disease Prevention in a Workplace Setting in ThailandChronic DiseaseNoncommunicable DiseasesNCT06265662Chulalongkorn University150
Unknown
不适用
An E-health Intervention for Patients With Peripheral Artery DiseaseIntermittent ClaudicationNCT05029739Sahlgrenska University Hospital155